Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 1

Status

Completed 4

Sponsor Class

OTHER 5INDUSTRY 4NETWORK 2

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 2Tumor-Agnostic 1Breast 1

Conditions

Brain Neoplasms 2Neoplasms 1Breast Neoplasms 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Gadolinium DTPA × Clear all
NCT00395863 2020-11-05

Multihance at 3 Tesla (3T) in Brain Tumors

Bracco Diagnostics, Inc

Phase 4 Completed
46 enrolled 18 charts
CNS

Brain Neoplasms

NCT01050829 2014-12-30

Gadobutrol Magnevist-controlled Body Study

Bayer

Phase 3 Completed
370 enrolled
Tumor-Agnostic

Neoplasms

NCT00681551 2014-12-15

Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis

Bayer

Phase 3 Completed
45 enrolled
CNS

Brain Neoplasms

NCT00486473 2010-07-15

DETECT

Bracco Diagnostics, Inc

Phase 3 Completed
130 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡